vs
Custom Truck One Source, Inc.（CTOS）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
Royalty Pharma plc的季度营收约是Custom Truck One Source, Inc.的1.5倍（$622.0M vs $422.2M），Royalty Pharma plc净利率更高（34.4% vs -4.2%，领先38.7%），Royalty Pharma plc同比增速更快（4.8% vs -8.5%），过去两年Custom Truck One Source, Inc.的营收复合增速更高（14.8% vs 4.6%）
Custom Truck One Source是北美领先的专用重型卡车及设备解决方案提供商，业务覆盖定制车辆制造、设备销售与租赁、售后配件供应及维保服务，主要服务基建、公用事业、建筑、能源等核心领域。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
CTOS vs RPRX — 直观对比
营收规模更大
RPRX
是对方的1.5倍
$422.2M
营收增速更快
RPRX
高出13.3%
-8.5%
净利率更高
RPRX
高出38.7%
-4.2%
两年增速更快
CTOS
近两年复合增速
4.6%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $422.2M | $622.0M |
| 净利润 | $-17.8M | $214.2M |
| 毛利率 | 20.3% | — |
| 营业利润率 | 2.9% | 62.4% |
| 净利率 | -4.2% | 34.4% |
| 营收同比 | -8.5% | 4.8% |
| 净利润同比 | -333.7% | 2.9% |
| 每股收益（稀释后） | $-0.08 | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CTOSRPRX
| Q1 26 | $422.2M | — | ||
| Q4 25 | $387.3M | $622.0M | ||
| Q3 25 | $359.9M | $609.3M | ||
| Q2 25 | $392.2M | $578.7M | ||
| Q1 25 | $307.1M | $568.2M | ||
| Q4 24 | $398.3M | $593.6M | ||
| Q3 24 | $337.5M | $564.7M | ||
| Q2 24 | $320.6M | $537.3M |
净利润CTOSRPRX
| Q1 26 | $-17.8M | — | ||
| Q4 25 | $20.9M | $214.2M | ||
| Q3 25 | $-5.8M | $288.2M | ||
| Q2 25 | $-28.4M | $30.2M | ||
| Q1 25 | $-17.8M | $238.3M | ||
| Q4 24 | $27.6M | $208.2M | ||
| Q3 24 | $-17.4M | $544.0M | ||
| Q2 24 | $-24.5M | $102.0M |
毛利率CTOSRPRX
| Q1 26 | 20.3% | — | ||
| Q4 25 | 31.8% | — | ||
| Q3 25 | 28.0% | — | ||
| Q2 25 | 26.1% | — | ||
| Q1 25 | 27.9% | — | ||
| Q4 24 | 29.7% | — | ||
| Q3 24 | 27.2% | — | ||
| Q2 24 | 27.8% | — |
营业利润率CTOSRPRX
| Q1 26 | 2.9% | — | ||
| Q4 25 | 13.4% | 62.4% | ||
| Q3 25 | 9.1% | 70.1% | ||
| Q2 25 | 7.1% | 36.3% | ||
| Q1 25 | 4.0% | 94.0% | ||
| Q4 24 | 16.9% | 60.9% | ||
| Q3 24 | 6.8% | — | ||
| Q2 24 | 5.5% | 50.2% |
净利率CTOSRPRX
| Q1 26 | -4.2% | — | ||
| Q4 25 | 5.4% | 34.4% | ||
| Q3 25 | -1.6% | 47.3% | ||
| Q2 25 | -7.2% | 5.2% | ||
| Q1 25 | -5.8% | 41.9% | ||
| Q4 24 | 6.9% | 35.1% | ||
| Q3 24 | -5.2% | 96.3% | ||
| Q2 24 | -7.6% | 19.0% |
每股收益（稀释后）CTOSRPRX
| Q1 26 | $-0.08 | — | ||
| Q4 25 | $0.10 | $0.49 | ||
| Q3 25 | $-0.03 | $0.67 | ||
| Q2 25 | $-0.13 | $0.07 | ||
| Q1 25 | $-0.08 | $0.55 | ||
| Q4 24 | $0.11 | $0.46 | ||
| Q3 24 | $-0.07 | $1.21 | ||
| Q2 24 | $-0.10 | $0.23 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $6.3M | $618.7M |
| 总债务越低越好 | $25.9M | $9.0B |
| 股东权益账面价值 | $809.1M | $9.7B |
| 总资产 | $3.4B | $19.6B |
| 负债/权益比越低杠杆越低 | 0.03× | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资CTOSRPRX
| Q1 26 | $6.3M | — | ||
| Q4 25 | $6.3M | $618.7M | ||
| Q3 25 | $13.1M | $938.9M | ||
| Q2 25 | $5.3M | $631.9M | ||
| Q1 25 | $5.4M | $1.1B | ||
| Q4 24 | $3.8M | $929.0M | ||
| Q3 24 | $8.4M | $950.1M | ||
| Q2 24 | $8.1M | $1.8B |
总债务CTOSRPRX
| Q1 26 | $25.9M | — | ||
| Q4 25 | $1.6B | $9.0B | ||
| Q3 25 | $1.6B | $8.9B | ||
| Q2 25 | $1.6B | $8.0B | ||
| Q1 25 | $1.6B | $7.6B | ||
| Q4 24 | $1.5B | $7.6B | ||
| Q3 24 | $1.6B | $7.6B | ||
| Q2 24 | $1.5B | $7.6B |
股东权益CTOSRPRX
| Q1 26 | $809.1M | — | ||
| Q4 25 | $809.1M | $9.7B | ||
| Q3 25 | $784.7M | $9.6B | ||
| Q2 25 | $790.1M | $9.5B | ||
| Q1 25 | $813.4M | $9.8B | ||
| Q4 24 | $861.3M | $10.3B | ||
| Q3 24 | $837.5M | $10.3B | ||
| Q2 24 | $856.7M | $9.8B |
总资产CTOSRPRX
| Q1 26 | $3.4B | — | ||
| Q4 25 | $3.4B | $19.6B | ||
| Q3 25 | $3.5B | $19.3B | ||
| Q2 25 | $3.6B | $18.3B | ||
| Q1 25 | $3.5B | $17.6B | ||
| Q4 24 | $3.5B | $18.2B | ||
| Q3 24 | $3.6B | $18.0B | ||
| Q2 24 | $3.5B | $17.7B |
负债/权益比CTOSRPRX
| Q1 26 | 0.03× | — | ||
| Q4 25 | 2.03× | 0.92× | ||
| Q3 25 | 2.10× | 0.93× | ||
| Q2 25 | 2.04× | 0.84× | ||
| Q1 25 | 1.97× | 0.78× | ||
| Q4 24 | 1.77× | 0.74× | ||
| Q3 24 | 1.87× | 0.74× | ||
| Q2 24 | 1.79× | 0.78× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $827.1M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | 3.86× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流CTOSRPRX
| Q1 26 | — | — | ||
| Q4 25 | $47.3M | $827.1M | ||
| Q3 25 | $81.5M | $702.6M | ||
| Q2 25 | $125.7M | $364.0M | ||
| Q1 25 | $55.6M | $596.1M | ||
| Q4 24 | $82.1M | $742.5M | ||
| Q3 24 | $16.5M | $703.6M | ||
| Q2 24 | $37.8M | $658.2M |
现金转化率CTOSRPRX
| Q1 26 | — | — | ||
| Q4 25 | 2.27× | 3.86× | ||
| Q3 25 | — | 2.44× | ||
| Q2 25 | — | 12.06× | ||
| Q1 25 | — | 2.50× | ||
| Q4 24 | 2.98× | 3.57× | ||
| Q3 24 | — | 1.29× | ||
| Q2 24 | — | 6.45× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CTOS
| Equipment sales | $273.9M | 65% |
| Rental revenue | $116.3M | 28% |
| Parts sales and services | $32.1M | 8% |
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
